PandemieGrippaleV1, PubMed, Curation, bibRecord, 000371

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

Identifieur interne : 000371 ( PubMed/Curation ); précédent : 000370; suivant : 000372

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

Auteurs : Abigail Eaton [États-Unis] ; Ned Lewis [États-Unis] ; Bruce Fireman [États-Unis] ; John Hansen [États-Unis] ; Roger Baxter [États-Unis] ; Julianne Gee [États-Unis] ; Nicola P. Klein [États-Unis]

Source :

Vaccine [ 1873-2518 ] ; 2018.

RBID : pubmed:28917536

Descripteurs français

KwdFr :
- Adulte, Avortement spontané (épidémiologie), Complications de la grossesse et maladies infectieuses (), Femelle, Grippe humaine (), Grossesse, Humains, Issue de la grossesse (épidémiologie), Mortinaissance (épidémiologie), Naissance prématurée (épidémiologie), Nourrisson petit pour son âge gestationnel, Nourrisson très faible poids naissance, Nouveau-né, Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H1N1 du virus de la grippe A (pathogénicité), Vaccins antigrippaux (usage thérapeutique), Études de cohortes.
MESH :
- immunologie : Sous-type H1N1 du virus de la grippe A.
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- usage thérapeutique : Vaccins antigrippaux.
- épidémiologie : Avortement spontané, Issue de la grossesse, Mortinaissance, Naissance prématurée.
- Adulte, Complications de la grossesse et maladies infectieuses, Femelle, Grippe humaine, Grossesse, Humains, Nourrisson petit pour son âge gestationnel, Nourrisson très faible poids naissance, Nouveau-né, Études de cohortes.

English descriptors

KwdEn :
- Abortion, Spontaneous (epidemiology), Adult, Cohort Studies, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza Vaccines (therapeutic use), Influenza, Human (prevention & control), Pregnancy, Pregnancy Complications, Infectious (prevention & control), Pregnancy Outcome (epidemiology), Premature Birth (epidemiology), Stillbirth (epidemiology).
MESH :
- chemical , therapeutic use : Influenza Vaccines.
- epidemiology : Abortion, Spontaneous, Pregnancy Outcome, Premature Birth, Stillbirth.
- immunology : Influenza A Virus, H1N1 Subtype.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- Adult, Cohort Studies, Female, Humans, Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Pregnancy.

Abstract

Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009-2010.

DOI: 10.1016/j.vaccine.2017.08.080
PubMed: 28917536

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000371

Links to Exploration step

pubmed:28917536

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.</title>
<author><name sortKey="Eaton, Abigail" sort="Eaton, Abigail" uniqKey="Eaton A" first="Abigail" last="Eaton">Abigail Eaton</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States. Electronic address: abigail.eaton@kp.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lewis, Ned" sort="Lewis, Ned" uniqKey="Lewis N" first="Ned" last="Lewis">Ned Lewis</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fireman, Bruce" sort="Fireman, Bruce" uniqKey="Fireman B" first="Bruce" last="Fireman">Bruce Fireman</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hansen, John" sort="Hansen, John" uniqKey="Hansen J" first="John" last="Hansen">John Hansen</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Baxter, Roger" sort="Baxter, Roger" uniqKey="Baxter R" first="Roger" last="Baxter">Roger Baxter</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gee, Julianne" sort="Gee, Julianne" uniqKey="Gee J" first="Julianne" last="Gee">Julianne Gee</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Klein, Nicola P" sort="Klein, Nicola P" uniqKey="Klein N" first="Nicola P" last="Klein">Nicola P. Klein</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:28917536</idno>
<idno type="pmid">28917536</idno>
<idno type="doi">10.1016/j.vaccine.2017.08.080</idno>
<idno type="wicri:Area/PubMed/Corpus">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000371</idno>
<idno type="wicri:Area/PubMed/Curation">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000371</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.</title>
<author><name sortKey="Eaton, Abigail" sort="Eaton, Abigail" uniqKey="Eaton A" first="Abigail" last="Eaton">Abigail Eaton</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States. Electronic address: abigail.eaton@kp.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lewis, Ned" sort="Lewis, Ned" uniqKey="Lewis N" first="Ned" last="Lewis">Ned Lewis</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fireman, Bruce" sort="Fireman, Bruce" uniqKey="Fireman B" first="Bruce" last="Fireman">Bruce Fireman</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hansen, John" sort="Hansen, John" uniqKey="Hansen J" first="John" last="Hansen">John Hansen</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Baxter, Roger" sort="Baxter, Roger" uniqKey="Baxter R" first="Roger" last="Baxter">Roger Baxter</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gee, Julianne" sort="Gee, Julianne" uniqKey="Gee J" first="Julianne" last="Gee">Julianne Gee</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Klein, Nicola P" sort="Klein, Nicola P" uniqKey="Klein N" first="Nicola P" last="Klein">Nicola P. Klein</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Vaccine</title>
<idno type="eISSN">1873-2518</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abortion, Spontaneous (epidemiology)</term>
<term>Adult</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Infant, Small for Gestational Age</term>
<term>Infant, Very Low Birth Weight</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term>
<term>Influenza Vaccines (therapeutic use)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Pregnancy</term>
<term>Pregnancy Complications, Infectious (prevention & control)</term>
<term>Pregnancy Outcome (epidemiology)</term>
<term>Premature Birth (epidemiology)</term>
<term>Stillbirth (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Avortement spontané (épidémiologie)</term>
<term>Complications de la grossesse et maladies infectieuses ()</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Issue de la grossesse (épidémiologie)</term>
<term>Mortinaissance (épidémiologie)</term>
<term>Naissance prématurée (épidémiologie)</term>
<term>Nourrisson petit pour son âge gestationnel</term>
<term>Nourrisson très faible poids naissance</term>
<term>Nouveau-né</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term>
<term>Vaccins antigrippaux (usage thérapeutique)</term>
<term>Études de cohortes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Abortion, Spontaneous</term>
<term>Pregnancy Outcome</term>
<term>Premature Birth</term>
<term>Stillbirth</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Avortement spontané</term>
<term>Issue de la grossesse</term>
<term>Mortinaissance</term>
<term>Naissance prématurée</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Infant, Small for Gestational Age</term>
<term>Infant, Very Low Birth Weight</term>
<term>Pregnancy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Complications de la grossesse et maladies infectieuses</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Nourrisson petit pour son âge gestationnel</term>
<term>Nourrisson très faible poids naissance</term>
<term>Nouveau-né</term>
<term>Études de cohortes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009-2010.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28917536</PMID>
<DateCompleted><Year>2018</Year>
<Month>12</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>36</Volume>
<Issue>19</Issue>
<PubDate><Year>2018</Year>
<Month>05</Month>
<Day>03</Day>
</PubDate>
</JournalIssue>
<Title>Vaccine</Title>
<ISOAbbreviation>Vaccine</ISOAbbreviation>
</Journal>
<ArticleTitle>Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.</ArticleTitle>
<Pagination><MedlinePgn>2733-2739</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)31180-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.08.080</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">Following the H1N1 influenza pandemic in 2009, pregnant women were recommended to receive both seasonal (TIV) and H1N1 influenza vaccines. This study presents incidence of adverse birth and pregnancy outcomes among a population of pregnant women immunized with TIV and H1N1 vaccines at Kaiser Permanente Northern California during 2009-2010.</AbstractText>
<AbstractText Label="METHODS">We telephone surveyed pregnant Kaiser Permanente Northern California members to assess non-medically-attended reactions following H1N1, TIV or both vaccines during 2009-2010 (n=5365) in a separate study. Here we assessed preterm birth (<37weeks), very preterm birth (<32weeks), low birth weight (<2500 g, LBW), very low birth weight (<1500g), small for gestational age, spontaneous abortions, stillbirths and congenital anomalies among this cohort by comparing incidence and 95% confidence intervals between the following immunization groups: TIV only, H1N1 only, H1N1 prior to TIV immunization, TIV prior to H1N1 and both immunizations given at the same time.</AbstractText>
<AbstractText Label="RESULTS">Results did not vary significantly between groups. Comparing H1N1 with TIV, incidence were similar for preterm births (6.37vs 6.28/100 births), very preterm births (5.30vs 8.29/1000 births), LBW (4.19vs 2.90/100 births), very LBW (4.54vs 5.52/1000 births), small for gestational age (9.99vs 9.24/1000 births), spontaneous abortion (7.10vs 6.83/1000 pregnancies), stillbirths (7.10vs 4.57/1000 pregnancies), and congenital anomalies (2.66vs 2.43/100 births).</AbstractText>
<AbstractText Label="CONCLUSIONS">Although constrained by small sample size, complex vaccine groups, and differential vaccine availability during 2009-2010, this study found no difference in adverse birth outcomes between H1N1 vaccine and TIV.</AbstractText>
<CopyrightInformation>Copyright © 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eaton</LastName>
<ForeName>Abigail</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States. Electronic address: abigail.eaton@kp.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lewis</LastName>
<ForeName>Ned</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fireman</LastName>
<ForeName>Bruce</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hansen</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baxter</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gee</LastName>
<ForeName>Julianne</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Klein</LastName>
<ForeName>Nicola P</ForeName>
<Initials>NP</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Vaccine Study Center and Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID>
<Agency>Intramural CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>09</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Vaccine</MedlineTA>
<NlmUniqueID>8406899</NlmUniqueID>
<ISSNLinking>0264-410X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000022" MajorTopicYN="N">Abortion, Spontaneous</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007236" MajorTopicYN="N">Infant, Small for Gestational Age</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019102" MajorTopicYN="N">Infant, Very Low Birth Weight</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050497" MajorTopicYN="N">Stillbirth</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">H1N1</Keyword>
<Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Pregnancy</Keyword>
<Keyword MajorTopicYN="Y">Safety</Keyword>
<Keyword MajorTopicYN="Y">Vaccines</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>08</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>08</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28917536</ArticleId>
<ArticleId IdType="pii">S0264-410X(17)31180-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.vaccine.2017.08.080</ArticleId>
<ArticleId IdType="pmc">PMC6708558</ArticleId>
<ArticleId IdType="mid">NIHMS1043623</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Obstet Gynecol. 2004 Nov;104(5 Pt 1):1125-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15516422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2008 Jan;8(1):44-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18156088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2009 Aug 8;374(9688):451-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19643469</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Obstet Gynecol. 2009 Summer;2(3):139-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19826571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2009 Dec;201(6):547-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19850275</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2010 Jan 7;362(1):27-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20032319</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2011 Feb;204(2):146.e1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20965490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2011 Jul;205(1):10-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21345415</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2011 Jun 14;342:d3214</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21672992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Mar 30;30(16):2671-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22342546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jan 24;368(4):333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23323868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2013 May;56(9):1216-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23378281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2013 Mar;121(3):511-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23635612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Oct 17;31(44):5033-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24016804</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Oct 17;31(44):5026-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24016809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Mar 5;32(11):1254-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24486369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Sep 3;32(39):4985-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25045808</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Dec 12;32(52):7057-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25285883</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Nov 12;32(48):6463-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25285884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Perinatol. 2015 May;32(6):571-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25607230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Apr 27;33(18):2108-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25758932</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Sep 11;33(38):4850-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26238723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Natl Vital Stat Rep. 2015 Dec;64(12):1-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26727629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 2017 Jun;99:111-117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28216380</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 1976 Nov 1;126(5):555-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">984126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000371 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000371 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28917536
   |texte=   Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28917536" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki